Axon Enterprise, Inc (NASDAQ:AXON) Shares Purchased by Spirepoint Private Client LLC

Spirepoint Private Client LLC raised its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 14.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,460 shares of the biotechnology company’s stock after acquiring an additional 2,339 shares during the quarter. Axon Enterprise makes up 1.3% of Spirepoint Private Client LLC’s portfolio, making the stock its 22nd biggest holding. Spirepoint Private Client LLC’s holdings in Axon Enterprise were worth $9,709,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently made changes to their positions in AXON. Brighton Jones LLC acquired a new position in shares of Axon Enterprise in the fourth quarter worth $480,000. Ieq Capital LLC raised its holdings in shares of Axon Enterprise by 10.5% in the fourth quarter. Ieq Capital LLC now owns 3,149 shares of the biotechnology company’s stock worth $1,872,000 after acquiring an additional 298 shares during the last quarter. Concurrent Investment Advisors LLC raised its holdings in shares of Axon Enterprise by 12.1% in the fourth quarter. Concurrent Investment Advisors LLC now owns 877 shares of the biotechnology company’s stock worth $521,000 after acquiring an additional 95 shares during the last quarter. Sigma Planning Corp raised its holdings in shares of Axon Enterprise by 61.9% in the fourth quarter. Sigma Planning Corp now owns 1,645 shares of the biotechnology company’s stock worth $978,000 after acquiring an additional 629 shares during the last quarter. Finally, Wealthspire Advisors LLC acquired a new position in shares of Axon Enterprise in the fourth quarter worth $220,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 905 shares of the business’s stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the transaction, the president now directly owns 268,735 shares of the company’s stock, valued at approximately $208,643,166.65. The trade was a 0.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction on Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 44,642 shares of company stock worth $30,500,428. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Trading Up 0.8%

NASDAQ AXON opened at $783.24 on Tuesday. Axon Enterprise, Inc has a one year low of $279.02 and a one year high of $806.64. The company’s 50 day moving average price is $696.32 and its 200 day moving average price is $625.93. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.62 and a current ratio of 2.83. The firm has a market capitalization of $60.98 billion, a price-to-earnings ratio of 189.19, a PEG ratio of 89.48 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. During the same quarter last year, the firm posted $1.15 earnings per share. Axon Enterprise’s revenue for the quarter was up 31.3% compared to the same quarter last year. On average, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on AXON shares. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. The Goldman Sachs Group lifted their price target on Axon Enterprise from $730.00 to $830.00 and gave the company a “buy” rating in a report on Wednesday, May 14th. Barclays increased their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. Bank of America increased their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a “buy” rating in a report on Wednesday, June 4th. Finally, Needham & Company LLC increased their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $699.55.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.